Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-18-021478

Chairman and CEO acquired 100,000 shares (grant or award)

  • Chairman and CEO gave up 24,373 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2018-03-23 Grant or award +100,000 $6.70 $670,000 5,930,270 D
KAZIMI A J Chairman and CEO 2018-03-23 Shares withheld for taxes −24,373 $6.70 $163,299 5,905,897 D
Loading xslF345X03/doc4.xml…